Critical Outcome Technologies Inc.

critical outcome p53 gene cancer ovarian cancer biotech coti-2 drug discovery rosalind chemsas artificial intelligence investor presentation oncology p53 cancer research biotechnology lung cancer drug development cot cotqf gynecological precision medicine personalized medicine clinical trial gene profiling orphan drug big data tsx personalized treatments breast cancer breakthrough life sciences healthcare cantech tsx-v coti kras personalized cancer care treatment options 48 hours in the hub boston cancer care defining personalized cancer care search for a cure companion diagnostics head and neck cancer biopharmaceutical md anderson cancer center equities.com small-cap breakthrough treatment phase 1 ind filing bio investor forum bioinformatics venture $cot #bif13 research and development r&d artificial intelligenc colon cancer pancreas pitchbook